ORYN THERAPEUTICS, Inc.
Biotechnology ResearchView the employees at
ORYN THERAPEUTICS, Inc.-
Anthony (TJ) Cabebe Research Scientist at Oryn Therapeutics & Research Technician II at Keck School of Medicine
-
Los Angeles Metropolitan Area
-
Rising Star
Jamie Schatz Financial Controller at ORYN THERAPEUTICS, LLC-
College Station, Texas, United States
-
Rising Star
Ana Krtolica SVP Preclinical Development at Oryn Therapeutics-
United States
-
Rising Star
Geeta Srivastava Senior Director, CMC, Oryn Therapeutics-
San Diego County, California, United States
-
Top 1%
Overview
Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides. These proprietary drug candidates are engineered, stable, cyclic peptides with very low immunogenicity and toxicity. They modulate pathologic inflammation and have proven effective in animal models of autoimmune and chronic inflammatory diseases such as rheumatoid arthritis and ulcerative colitis. They have proven effective in preclinical cancer models and augment natural host defense, functioning as host-directed anti-infectives against drug resistant pathogens.
-